Related Experiment Video
Updated: Nov 7, 2025

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Moxifloxacin Monotherapy in Left-Sided Staphylococcus aureus Endocarditis
1Department of Cardiology, Erdem Hospital, Istanbul, Turkey.
Abstract:
Staphylococcus aureus is the major cause of endocarditis, and its mortality has remained high despite therapeutic procedures over time. A case of left-sided native valve endocarditis caused by methicillin-sensitive Staphylococcus aureus which responded well to moxifloxacin monotherapy is described. An 83-year-old woman with a history of current hospitalization presented with fatigue and fever. Transthoracic echocardiography depicted vegetation, and blood cultures were positive for Staphylococcus aureus. After a 14-day intravenous administration of moxifloxacin, a good clinical response was achieved, and antibiotic regimen transitioned to oral moxifloxacin for an additional four-week therapy.
Insights
This case study highlights a successful treatment of Staphylococcus aureus endocarditis using moxifloxacin monotherapy. The findings suggest moxifloxacin as a potential therapeutic option for this serious infection.
Area of Science:
- Infectious Diseases
- Cardiology
- Pharmacology
Background:
- Staphylococcus aureus is a leading cause of infective endocarditis, a serious condition with high mortality rates.
- Despite advancements in treatment, mortality for S. aureus endocarditis remains a significant clinical challenge.
- Native valve endocarditis requires effective antimicrobial strategies.
Observation:
- An 83-year-old female patient presented with symptoms of fatigue and fever.
- Transthoracic echocardiography revealed vegetation on the heart valve.
- Blood cultures confirmed the presence of methicillin-sensitive Staphylococcus aureus.
Findings:
- The patient received a 14-day course of intravenous moxifloxacin.
- A subsequent four-week oral moxifloxacin regimen was administered.
- The patient demonstrated a positive clinical response to moxifloxacin monotherapy.
Implications:
- Moxifloxacin monotherapy may be an effective treatment option for left-sided native valve endocarditis caused by S. aureus.
- This case suggests a potential alternative to combination antibiotic therapies.
- Further research is warranted to evaluate the efficacy and safety of moxifloxacin in a larger patient cohort.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Mitral Stenosis III: Medical Management
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

